Patent Term Extension Application for LEROCHOL® (lerodalcibep-liga), Patent No. 10,738,102 | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

FDA-2026-E-3817

Patent Term Extension Application for LEROCHOL® (lerodalcibep-liga), Patent No. 10,738,102

Documents

Comments

Description

OPEN

Comment Period OpensApr 9, 2026

Type	Title	Posted	Comments	Status
Other	Letter from U. S. Patent and Trademark Office to FDA CDER	Apr 9, 2026	--

CDER

Patent Term Extension Application

Morgan, Lewis & Bockius LLP

LIB Therapeutics, Inc.

LEROCHOL® (lerodalcibep-liga)

Patent No. 10,738,102

OPEN